Pacific Biosciences: Mark Van Oene, Peter Fromen
Pacific Biosciences announced it has appointed Mark Van Oene to the newly created role of chief operating officer and Peter Fromen as chief commercial officer (CCO), both effective Jan. 8, 2021.
Van Oene joins PacBio after 15 years at Illumina, where he most recently served as senior VP and CCO and oversaw worldwide sales and service. He will be responsible for managing PacBio’s research, development, and manufacturing organizations and for driving strategic planning and corporate development activities.
